ArticleNeoplasia (New York, N.Y.)2017

Digoxin Plus Trametinib Therapy Achieves Disease Control in BRAF Wild-Type Metastatic Melanoma Patients.

Arthur E Frankel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.